Novonesis

At Novonesis, we believe solutions rooted in biology are key to tackling the challenges our world faces. We develop and sell enzymes and functional proteins as well as microorganisms such as cultures, probiotics, postbiotics and yeast. These are some of our planet's tiniest, yet mightiest agents of change. When we leverage their power with our technology to solve problems, we create what we call biosolutions. And they’re revolutionizing the way we all produce, consume and live. Today we are 10,000 people worldwide with expertise that spans more than 30 industries. All around the world our biosolutions are already helping companies balance their business needs with those of our planet. The time for biosolutions is now. And by working closely with our partners and customers, we will continue to challenge conventional thinking and transform business with biology. Together we will create the change our world needs. Chr. Hansen and Novozymes joined forces in January 2024 to create Novonesis, positioning it as a leading global biosolutions partner. The company aims to leverage the power of biology to drive positive change. By combining the expertise of both legacy companies, Novonesis is poised to contribute to better business practices, healthier lives, and a more sustainable planet.